[{"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsIntervention group: Modafinil (100 mg Tablets) is administered orally or by gavage at the rate of 100 mg every 8 hours and in case of no complications or changes in hemodynamics, 100 mg every two hours is re-prescribed up to 400 mg, reach the total dose (plasma peak of the drug is 2-4 hours). Two hours after each dose and before the next dose and two hours after the last dose (10, 12, 14 and 16 hours) consciousness (initial outcome) was assessed and in case of significant improvement in the level of consciousness according to Glasgow criteria coma scale (GCS) The drug is continued for up to two weeks at a dose of 400 mg daily and will be discontinued if there is no change in consciousness according to the GCS standard. In addition, all treatment measures will be conducted according to the national therapeutic protocol for the patients.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsControl group: In this group, placebo will be prescribe to the patients which have no therapeutic effect and are similar in color and shape to Medafinil tablets.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 810, "treatment_name": "Modafinil", "treatment_type": "Central nervous system agents", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]